VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy
Angiogenesis has been targeted in retinopathies, psoriasis, and a variety of cancers (colon, breast, lung, and kidney). Among these tumour types, clear cell renal cell carcinomas (RCCs) are the most vascularized tumours due to mutations of the von Hippel Lindau gene resulting in HIF-1 alpha stabilis...
Saved in:
Main Authors: | Caroline Hilmi, Mélanie Guyot, Gilles Pagès |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Journal of Nucleic Acids |
Online Access: | http://dx.doi.org/10.1155/2012/162692 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
by: Kenichi Kimoto, et al.
Published: (2012-01-01) -
Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
by: Selwyn M. Prea, et al.
Published: (2015-01-01) -
Anti-VEGF Cancer Therapy in Nephrology Practice
by: Hassan Izzedine
Published: (2014-01-01) -
Alternative Splicing: Emerging Roles in Anti-Aging Strategies
by: Lingyue Gao, et al.
Published: (2025-01-01) -
Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians
by: Pearse A. Keane, et al.
Published: (2012-01-01)